What diseases is Ustekinumab mainly used to treat?

Ustekinumab is a humanized monoclonal antibody targeting interleukin 12 (IL-12) and interleukin 23 (IL-23). It regulates abnormal activation of the immune system by inhibiting these two key inflammatory mediators, thereby alleviating a variety of immune-mediated inflammatory diseases. Ustekinumab has become an important treatment option for a variety of chronic inflammatory diseases due to its unique mechanism of action and good efficacy.

Ustekinumab is widely used to treat moderate to severe plaque psoriasis (psoriatic skin disease). The disease is an autoimmune skin disease characterized by erythema, scales and itching of the skin. By targeting IL-12 and IL-23, ustekinumab inhibits the inflammatory pathway, effectively reduces skin lesions, and improves patients' skin symptoms and quality of life. Clinical studies have shown that ustekinumab significantly improves skin lesion clearance in patients with psoriasis.

Ustekinumab is approved to treat psoriatic arthritis, a chronic inflammatory disease that affects the joints and skin. By regulating the inflammatory response, ustekinumab can reduce joint pain and swelling, prevent the progression of joint damage, and improve patients' motor function and quality of life. The drug has a stable effect in the treatment of arthritis and has good safety profile.

Ustekinumab is also used to treat moderately to severely active Crohn's disease. Crohn's disease is a chronic inflammatory disease of the intestines that causes abdominal pain, diarrhea, and weight loss. Ustekinumab reduces intestinal inflammation and promotes disease remission by inhibiting abnormal activation of the immune system. The drug provides new treatment hope for many patients who have failed to respond to traditional treatments.

In summary, ustekinumab is mainly used for immune-mediated chronic inflammatory diseases such as plaque psoriasis, psoriatic arthritis and Crohn's disease. With its precise targeting, significant efficacy and good safety, ustekinumab plays an important role in the treatment of these diseases, helping patients to effectively control symptoms and improve their quality of life.

Reference materials:https://www.drugs.com